East West Capital Partners facilitated a strategic investment in ITL Health Group Limited, a prominent Australian medtech firm, to enhance its growth potential in the global healthcare market.
Target Information
East West Capital Partners (EWCP) has successfully advised a strategic investor to acquire a substantial stake in ITL Health Group Limited. This Australian medtech company is listed on the ASX under the stock ticker ITD: AX and is renowned for its innovative medical technology products. ITL supplies its diverse range of offerings to more than 35 countries worldwide, establishing itself as a key player in the global healthcare market.
ITL Health Group's core operations focus on manufacturing products aimed at safeguarding the health and safety of healthcare professionals. The company specializes in blood-banking solutions while also offering various other cutting-edge products intended for general medical applications. ITL is proud to hold multiple patents and produces its medical devices at a state-of-the-art facility located in Ipoh, Malaysia.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Australia
The Australian medtech industry has experienced significant growth in recent years, driven by an aging population and increasing demand for innovative healthcare solutions. Wi
Similar Deals
Cadwell Industries, Inc. → Seer Medical
2025
Caring Brands International → Just Better Care
2014
Boston Scientific → Nalu Medical
2026
East West Capital Partners
invested in
ITL Health Group Limited
in
in a Strategic Partnership deal